Skip to content

Enalapril

Epaned, Vasotec (enalapril) is a small molecule pharmaceutical. Enalapril was first approved as Epaned on 1985-12-24. It is used to treat bartter syndrome, diabetic nephropathies, edema, heart failure, and left ventricular dysfunction amongst others in the USA. The pharmaceutical is active against angiotensin-converting enzyme. Vasotec's patents are valid until 2036-03-25 (FDA).
Trade Name Epaned, Vasotec
Common Name Enalapril
Indication bartter syndrome, diabetic nephropathies, edema, heart failure, left ventricular dysfunction, malignant hypertension, rheumatoid arthritis
Drug Class Narcotic agonists/antagonists (normorphine type); antihypertensives (ACE inhibitors)
Enalapril
Get full access now